Cargando…
Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response
Cyclin-dependent kinases (CDKs) are pivotal mediators and effectors of the DNA damage response (DDR) that regulate both the pathway components and proteins involved in repair processes. Synthetic lethality (SL) describes a situation in which two genes are linked in such a way that the lack of functi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998982/ https://www.ncbi.nlm.nih.gov/pubmed/35408915 http://dx.doi.org/10.3390/ijms23073555 |
_version_ | 1784685076379860992 |
---|---|
author | Kciuk, Mateusz Gielecińska, Adrianna Mujwar, Somdutt Mojzych, Mariusz Kontek, Renata |
author_facet | Kciuk, Mateusz Gielecińska, Adrianna Mujwar, Somdutt Mojzych, Mariusz Kontek, Renata |
author_sort | Kciuk, Mateusz |
collection | PubMed |
description | Cyclin-dependent kinases (CDKs) are pivotal mediators and effectors of the DNA damage response (DDR) that regulate both the pathway components and proteins involved in repair processes. Synthetic lethality (SL) describes a situation in which two genes are linked in such a way that the lack of functioning of just one maintains cell viability, while depletion of both triggers cell death. Synthetic lethal interactions involving CDKs are now emerging, and this can be used to selectively target tumor cells with DNA repair defects. In this review, SL interactions of CDKs with protooncogene products MYC, poly (ADP-ribose) polymerase (PARP-1), and cellular tumor antigen p53 (TP53) are discussed. The individual roles of each of the SL partners in DDR are described. |
format | Online Article Text |
id | pubmed-8998982 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89989822022-04-12 Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response Kciuk, Mateusz Gielecińska, Adrianna Mujwar, Somdutt Mojzych, Mariusz Kontek, Renata Int J Mol Sci Review Cyclin-dependent kinases (CDKs) are pivotal mediators and effectors of the DNA damage response (DDR) that regulate both the pathway components and proteins involved in repair processes. Synthetic lethality (SL) describes a situation in which two genes are linked in such a way that the lack of functioning of just one maintains cell viability, while depletion of both triggers cell death. Synthetic lethal interactions involving CDKs are now emerging, and this can be used to selectively target tumor cells with DNA repair defects. In this review, SL interactions of CDKs with protooncogene products MYC, poly (ADP-ribose) polymerase (PARP-1), and cellular tumor antigen p53 (TP53) are discussed. The individual roles of each of the SL partners in DDR are described. MDPI 2022-03-24 /pmc/articles/PMC8998982/ /pubmed/35408915 http://dx.doi.org/10.3390/ijms23073555 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Kciuk, Mateusz Gielecińska, Adrianna Mujwar, Somdutt Mojzych, Mariusz Kontek, Renata Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response |
title | Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response |
title_full | Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response |
title_fullStr | Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response |
title_full_unstemmed | Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response |
title_short | Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response |
title_sort | cyclin-dependent kinase synthetic lethality partners in dna damage response |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998982/ https://www.ncbi.nlm.nih.gov/pubmed/35408915 http://dx.doi.org/10.3390/ijms23073555 |
work_keys_str_mv | AT kciukmateusz cyclindependentkinasesyntheticlethalitypartnersindnadamageresponse AT gielecinskaadrianna cyclindependentkinasesyntheticlethalitypartnersindnadamageresponse AT mujwarsomdutt cyclindependentkinasesyntheticlethalitypartnersindnadamageresponse AT mojzychmariusz cyclindependentkinasesyntheticlethalitypartnersindnadamageresponse AT kontekrenata cyclindependentkinasesyntheticlethalitypartnersindnadamageresponse |